|
Volumn 12, Issue 2, 2000, Pages 123-130
|
A new Doppler signal enhancing agent for flow assessment in breast lesions
|
Author keywords
Angiogenesis; Breast neoplasm; Contrast enhancement; Doppler; Vascularity
|
Indexed keywords
CONTRAST MEDIUM;
SONOVUE;
ADULT;
AGED;
ARTICLE;
B SCAN;
BENIGN TUMOR;
BREAST CARCINOMA;
BREAST TUMOR;
CLINICAL TRIAL;
CONTRAST ENHANCEMENT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DIAGNOSTIC ACCURACY;
DIFFERENTIAL DIAGNOSIS;
DOPPLER ECHOGRAPHY;
DOSE RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NAUSEA;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
SINGLE BLIND PROCEDURE;
ADULT;
BREAST NEOPLASMS;
CONTRAST MEDIA;
CROSS-OVER STUDIES;
FEMALE;
HUMANS;
INJECTIONS, INTRAVENOUS;
MIDDLE AGED;
PHOSPHOLIPIDS;
REGIONAL BLOOD FLOW;
SULFUR HEXAFLUORIDE;
ULTRASONOGRAPHY, DOPPLER;
ULTRASONOGRAPHY, MAMMARY;
VIDEOTAPE RECORDING;
|
EID: 0034548890
PISSN: 09298266
EISSN: None
Source Type: Journal
DOI: 10.1016/S0929-8266(00)00105-1 Document Type: Article |
Times cited : (45)
|
References (11)
|